Tip theo, bnh nhn c chia ngu nhin thnh hai nhm, l nhm tip tc dng tirzepatide v nhm chuyn sang dng gi dc, d vn duy tr ch n ung v tp luyn
The company describes retatrutide as an investigational once-weekly triple-hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors with a single molecule.[4] This development history is important because retatrutide was designed as a next-generation incretin therapy rather than as a simple modification of an existing GLP-1 agent
Figure 2 When any component of the insulin signaling pathway fails, it can lead to insulin resistance
Patients should also maintain a blood pressure monitor if they have hypertension, as cardiovascular risk factor management is integral to diabetes care
The structural damage is irreversible
Semaglutide, a GLP-1 receptor agonist, is an effective weight loss treatment used alongside lifestyle changes